Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Clinical trial NCT01151098 · COMPLETED

Trial details

NCT number: NCT01151098
Sponsor: Purdue Pharma LP
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Nonmalignant Pain

Start date: 2001-04-01
Primary completion: 2002-02-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.